Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
- 1 June 1998
- Vol. 29 (2), 142-147
- https://doi.org/10.1002/(sici)1098-2396(199806)29:2<142::aid-syn5>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography methodProceedings of the National Academy of Sciences, 1997
- Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaAmerican Journal of Psychiatry, 1994
- Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1993
- Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?Schizophrenia Bulletin, 1990
- In vivo presynaptic control of dopamine release in the cat caudate nucleus—II. Facilitatory or inhibitory influence ofl-glutamateNeuroscience, 1986
- Local Changes in Cerebral Glucose Utilization during Ketamine AnesthesiaAnesthesiology, 1982
- Inhibition of mammalian brain acetylcholinesterase by ketamineBiochemical Pharmacology, 1974
- Dissociative AnesthesiaAnesthesia & Analgesia, 1966
- Observations on the psychotomimetic effects of sernylComprehensive Psychiatry, 1961
- Observations on the Action of Sernyl — A New Psychotropic DrugCanadian Psychiatric Association Journal, 1961